Those with certain FTO variants may require higher exercise volumes or strength training emphasis to prevent metabolic adaptation as weight decreases
In models of hypertension, BPC-157 showed blood pressure-lowering effects, while in hypotensive states, it supported pressure normalization, suggesting homeostatic regulation rather than unidirectional cardiovascular effects
This is the only weight loss medication that works in the gut rather than the brain
10.1038/s41598-017-10524-6 Summary Keywords valproic acid, acylcarnitines, fatty acid -oxidation, peroxisome proliferator-activated receptor , hepatotoxicity Citation Ma Y, Wang M, Guo S, Li T, Liu X and Zhao L (2022) The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injury